Renal Cell Carcinoma Marketed and Pipeline Drugs Market is a type of kidney cancer that originates in the lining of the proximal convoluted tubule. RCC is the most common type of kidney cancer in adults. While it is considered one of the most lethal urological cancers, the causes of RCC are largely unknown. The most important known etiological risk factors, all of which are modifiable, are tobacco use, high blood pressure, and obesity.
The renal cell carcinoma marketed and pipeline drugs market report provides a data-driven overview of the current and future competitive landscape in renal cell carcinoma therapeutics.
|